| Generic Name | Brand Name |
|---|---|
| amlodipine besylate | Norvasc |
| diltiazem hydrochloride | Cardizem, Tiazac |
| felodipine | Plendil |
| nifedipine | Adalat |
| verapamil hydrochloride | Isoptin SR |
Calcium channel blockers help treat coronary artery disease by:
Calcium channel blockers are commonly used in people with coronary artery disease who have one or more of the following conditions:1
Calcium channel blockers can help reduce the severity and frequency of chest pain when beta-blockers cannot be used.1 Unlike beta-blockers, however, these medications do not reduce your risk of a future heart attack.
Side effects vary depending on the drug, but may include:
Nifedipine, verapamil, and diltiazem may cause skin rash or breast enlargement.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Calcium channel blockers are most effective when they are combined with nitrates and beta-blockers, but their dosage must be monitored carefully to prevent side effects. Nifedipine, amlodipine, and felodipine are used most commonly in people already taking beta-blockers. You can also take amlodipine in a combination dose with the statin atorvastatin, which treats high cholesterol. Therefore, this combination helps reduce chest pain and treats high cholesterol at the same time.
In general, the long-acting forms (taken once a day) of calcium channel blockers are preferred over the short-acting forms (taken 2 to 4 times per day).
Verapamil, diltiazem, and nifedipine may worsen heart failure. Amlodipine and felodipine do not appear to worsen heart failure.
Verapamil or diltiazem sometimes are used when a person cannot take beta-blockers.
Complete the new medication information form (PDF) (What is a PDF document?) to help you understand this medication.
Citations
- Snow V, et al. (2004). Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 141(7): 562–567. Also available online: http://www.annals.org/cgi/reprint/141/7/562.pdf.
Last Revised: August 12, 2010
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.